Comparing Medical Body Composition Analyzer Seca mBCA 555 With Seca mBCA 515
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04030416|
Recruitment Status : Recruiting
First Posted : July 24, 2019
Last Update Posted : July 24, 2019
The mBCA 515 was compared to the gold standard methods MRI, DXA, ADP, D2O- and NaBr-dilution in previous clinical investigations (BCA-01, BCA-02, BCA-20) to generate prediction equations for calculating body composition (FFM, SMM, ECW, TBW and VAT) in different populations. Furthermore, normal ranges for body composition were generated based on the previous study BCA-03 conducted at the UKE.
The mBCA 555 is a new body composition analyzer measuring bioimpedance in standing position developed by seca.
In order to apply prediction equations and normal ranges from previous clinical investigations BCA-01, BCA-02, BCA-03 and BCA-20 to the new mBCA 555 it shall be compared to the mBCA 515.
|Condition or disease|
|Bioelectrical Impedance Measurement of Healthy Adults|
|Study Type :||Observational|
|Estimated Enrollment :||120 participants|
|Official Title:||Clinical Accuracy Validation of the Medical Body Composition Analyzer Seca mBCA 555 in Comparison to Seca mBCA 515|
|Actual Study Start Date :||June 20, 2019|
|Estimated Primary Completion Date :||October 31, 2019|
|Estimated Study Completion Date :||October 31, 2019|
- BIA 5 and 50 kHz [ Time Frame: 10 minutes ]Bioelectrical Impedance of 5 and 50 kHz for one body side
- BIA 50 kHz [ Time Frame: 10 minutes ]Bioelectrical Impedance of 50 kHz for all 4 extremities
- Complete BIA [ Time Frame: 10 minutes ]Bioelectrical Impedance of 1, 1.5, 2, 3, 7.5, 10, 15, 20, 30, 75, 100, 150, 200, 300, 500, 750 and 1,000 kHz for all body segments: right arm, left arm, right leg, left leg, trunk, right body side and left body side.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04030416
|Contact: Kristin Klückmann||+4940200000 ext 232||Kristin.Klueckmann@seca.com|
|Institute of Transfusion Medicine||Recruiting|
|Hamburg, Germany, 20246|
|Contact: Sven Peine, Dr. email@example.com|
|Principal Investigator:||Sven Peine, Dr.||Universitätsklinikum Hamburg-Eppendorf|